Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check6 days agoChange DetectedThe study record gains two new Japan cross-reference identifiers: JapicCTI-194697 and jRCT2080224625. It also updates the record with a newer revision tag (Revision: v3.6.3) and recent dates, reflecting metadata enhancements to the entry.SummaryDifference0.2%

- Check13 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous v3.6.0. This represents a minor metadata update with no changes to study data or functionality.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now communicates that no participants are being enrolled for this rollover study and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting changes and the revision version are updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check34 days agoChange DetectedA new page revision is introduced, showing revision v3.5.5 and replacing v3.5.4. This indicates a page-level update and does not change the study details or their presentation.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.5.4 was added and Revision: v3.5.3 removed. This indicates a minor update to the page's metadata rather than substantive changes to study content.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page shows Revision: v3.5.3, indicating a software/template version update. This update is a backend version bump and does not modify the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.